Third Point’s St Jude Medical STJ Stock Holding History

Third Point’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,600,000	Closed	-$207M	–	48
2016 Q3	$207M	Buy	+2,600,000	New	+$210M	1.8%	20

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Third Point's STJ Position: Q4 2016 in Review

Third Point sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 2,600,000 shares — an estimated $207M sold.

Third Point first reported a position in STJ in Q3 2016 and held it in 1 quarter. The position peaked at $207M in Q3 2016. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

Third Point reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
Third Point sold 2,600,000 St Jude Medical shares in Q4 2016, an estimated $207M.
Third Point first reported a position in St Jude Medical in Q3 2016 and held it in 1 quarter.
Third Point's St Jude Medical position peaked at $207M in Q3 2016.
551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Third Point's 13F filing for Q4 2016, filed 10 Feb 2017.